Toshio Matsumoto

20.8k total citations · 1 hit paper
399 papers, 15.5k citations indexed

About

Toshio Matsumoto is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Toshio Matsumoto has authored 399 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Molecular Biology, 114 papers in Oncology and 80 papers in Orthopedics and Sports Medicine. Recurrent topics in Toshio Matsumoto's work include Bone health and treatments (76 papers), Bone health and osteoporosis research (76 papers) and Bone Metabolism and Diseases (61 papers). Toshio Matsumoto is often cited by papers focused on Bone health and treatments (76 papers), Bone health and osteoporosis research (76 papers) and Bone Metabolism and Diseases (61 papers). Toshio Matsumoto collaborates with scholars based in Japan, United States and China. Toshio Matsumoto's co-authors include Masahiro Abe, Yasuhiro Takeuchi, Etsuro Ogata, Shuji Ozaki, Masashi Akaike, Seiji Fukumoto, Shinsuke Kido, Takao Mitsui, Shigeaki Kato and Hiroyuki Azuma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Toshio Matsumoto

390 papers receiving 15.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

1997 872 citations Tatsuya Yoshizawa, Yoshikatsu Uematsu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshio Matsumoto Japan	65	6.2k	4.0k	2.9k	2.9k	1.7k	399	15.5k
Roland Baron United States	80	14.8k 2.4×	7.5k 1.9×	1.6k 0.6×	3.7k 1.3×	2.9k 1.7×	252	22.7k
Geert Carmeliet Belgium	63	5.2k 0.9×	1.7k 0.4×	5.3k 1.8×	1.9k 0.6×	1.8k 1.1×	191	15.4k
David Goltzman Canada	82	8.8k 1.4×	6.9k 1.7×	3.8k 1.3×	4.7k 1.6×	2.8k 1.6×	410	21.0k
Robert S. Weinstein United States	82	11.2k 1.8×	7.8k 1.9×	1.6k 0.6×	7.8k 2.7×	2.8k 1.6×	224	24.5k
Karl Insogna United States	66	5.9k 1.0×	5.2k 1.3×	1.4k 0.5×	3.2k 1.1×	1.9k 1.1×	237	15.1k
Johannes P.T.M. van Leeuwen Netherlands	71	6.0k 1.0×	2.3k 0.6×	4.7k 1.6×	4.5k 1.6×	3.2k 1.9×	346	18.4k
Lorraine A. Fitzpatrick United States	62	3.7k 0.6×	3.3k 0.8×	1.3k 0.4×	3.5k 1.2×	2.4k 1.4×	215	14.8k
Stuart H. Ralston United Kingdom	79	6.3k 1.0×	6.8k 1.7×	2.0k 0.7×	5.9k 2.0×	2.3k 1.4×	326	17.7k
David E.C. Cole Canada	58	3.3k 0.5×	1.9k 0.5×	2.9k 1.0×	1.3k 0.4×	3.1k 1.8×	282	12.8k
Stavros C. Manolagas United States	76	14.1k 2.3×	8.3k 2.1×	2.4k 0.8×	6.7k 2.3×	3.4k 2.0×	140	23.0k

Countries citing papers authored by Toshio Matsumoto

Since Specialization

Citations

This map shows the geographic impact of Toshio Matsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshio Matsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshio Matsumoto more than expected).

Fields of papers citing papers by Toshio Matsumoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshio Matsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshio Matsumoto. The network helps show where Toshio Matsumoto may publish in the future.

Co-authorship network of co-authors of Toshio Matsumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Toshio Matsumoto. A scholar is included among the top collaborators of Toshio Matsumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshio Matsumoto. Toshio Matsumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsumoto, Toshio, et al.. (2024). The Impact of Increased PEEP on Hemodynamics, Respiratory Mechanics, and Oxygenation in Pediatric ARDS. Respiratory Care. 69(11). 1409–1416. 3 indexed citations

Yamamoto, Yoko, Shigeaki Kato, Tatsuya Takemoto, et al.. (2023). VDR is an essential regulator of hair follicle regression through the progression of cell death. Life Science Alliance. 6(11). e202302014–e202302014. 8 indexed citations

Kurahashi, Kiyoe, Sumiko Yoshida, Toshiki Otoda, et al.. (2021). Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes. Journal of Diabetes Investigation. 12(12). 2172–2182. 5 indexed citations

Okazaki, Ryo, Keiichi Ozono, Seiji Fukumoto, et al.. (2016). Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion]. Journal of Bone and Mineral Metabolism. 35(1). 1–5. 77 indexed citations

Endo, Itsuro & Toshio Matsumoto. (2013). [Bone architecture and strength on unloading].. PubMed. 23(7). 1013–9. 2 indexed citations

Yoshida, Sumiko, Ken‐ichi Aihara, Yasumasa Ikeda, et al.. (2013). Androgen Receptor Promotes Sex-Independent Angiogenesis in Response to Ischemia and Is Required for Activation of Vascular Endothelial Growth Factor Receptor Signaling. Circulation. 128(1). 60–71. 50 indexed citations

Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma. International Journal of Hematology. 97(6). 743–748. 20 indexed citations

Ohshima, Hiroshi & Toshio Matsumoto. (2012). [Space flight/bedrest immobilization and bone. Bone metabolism in space flight and long-duration bed rest].. PubMed. 22(12). 1803–12. 4 indexed citations

Kuroda, Akio, Tetsuyuki Yasuda, Mitsuyoshi Takahara, et al.. (2012). Carbohydrate-to-Insulin Ratio Is Estimated from 300–400 Divided by Total Daily Insulin Dose in Type 1 Diabetes Patients Who Use the Insulin Pump. Diabetes Technology & Therapeutics. 14(11). 1077–1080. 11 indexed citations

10.

Terao, Kimio, Takehiko Kawanishi, Masataka Shiraki, et al.. (2011). Pharmacokinetics of eldecalcitol in primary osteoporosis patients - Randomized, double-blind, multicentre, long-term phase III clinical study. 39(3). 299–307. 4 indexed citations

11.

Endo, Itsuro & Toshio Matsumoto. (2011). [Eldecalcitol (ED-71)].. PubMed. 21(1). 53–8. 1 indexed citations

12.

Ise, Takayuki, Ken‐ichi Aihara, Sumiko Yoshida, et al.. (2010). Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors. Hypertension Research. 34(2). 225–231. 6 indexed citations

13.

Fujimura, Mitsunori, Masashi Akaike, Takashi Iwase, et al.. (2009). Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure. Acta Cardiologica. 64(5). 589–595. 4 indexed citations

14.

Wang, Wei, Yasuhiko Nishioka, Shuji Ozaki, et al.. (2008). HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody. Cancer Immunology Immunotherapy. 58(6). 967–976. 54 indexed citations

15.

Mitsui, Takao, et al.. (2007). Beneficial Effect of Tacrolimus on Myasthenia Gravis With Thymoma. The Neurologist. 13(2). 83–86. 13 indexed citations

16.

Fujimura, Mitsunori, Masashi Akaike, Midori Kato, et al.. (2003). Aggressive Antiplatelet Therapy Before Coronary Stent Implantation in Acute Coronary Syndrome with Essential Thrombocythemia. Angiology. 54(4). 485–490. 5 indexed citations

17.

Yagishita, Naoko, Yoko Yamamoto, Tatsuya Yoshizawa, et al.. (2001). Aberrant Growth Plate Development in VDR/RXRγ Double Null Mutant Mice. Endocrinology. 142(12). 5332–5341. 38 indexed citations

18.

Hirabayashi, Masayuki, et al.. (2000). HII/L2 Mission Cryogenic System. JAXA Repository (JAXA). 14(14). 323–330. 2 indexed citations

19.

Hayakawa, S., et al.. (1981). Distribution of near infrared sources in the galactic disk.. A&A. 100. 116–123. 2 indexed citations

20.

Horiuchi, Noboru, Hiroo Takahashi, Toshio Matsumoto, et al.. (1979). Salmon calcitonin-induced stimulation of 1α,25-dihydroxycholecalciferol synthesis in rats involving a mechanism independent of adenosine 3′:5′-cyclic monophosphate. Biochemical Journal. 184(2). 269–275. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact